213 related articles for article (PubMed ID: 36687376)
1. Drop-on-powder 3D printing of amorphous high dose oral dosage forms: Process development, opportunities and printing limitations.
Gottschalk N; Burkard A; Quodbach J; Bogdahn M
Int J Pharm X; 2023 Dec; 5():100151. PubMed ID: 36687376
[TBL] [Abstract][Full Text] [Related]
2. 3D printing of amorphous solid dispersions: A comparison of fused deposition modeling and drop-on-powder printing.
Gottschalk N; Bogdahn M; Quodbach J
Int J Pharm X; 2023 Dec; 5():100179. PubMed ID: 37025187
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Assessment of Cocrystal and Amorphous Solid Dispersion Printlets Developed by Hot Melt Extrusion Paired Fused Deposition Modeling for Dissolution Enhancement and Stability of Ibuprofen.
Mandati P; Nyavanandi D; Narala S; Alzahrani A; Vemula SK; Repka MA
AAPS PharmSciTech; 2023 Oct; 24(7):203. PubMed ID: 37783961
[TBL] [Abstract][Full Text] [Related]
4. Orodispersible Polymer Films with the Poorly Water-Soluble Drug, Olanzapine: Hot-Melt Pneumatic Extrusion for Single-Process 3D Printing.
Cho HW; Baek SH; Lee BJ; Jin HE
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32707862
[TBL] [Abstract][Full Text] [Related]
5. Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques?
Parulski C; Gresse E; Jennotte O; Felten A; Ziemons E; Lechanteur A; Evrard B
Int J Pharm; 2022 Oct; 626():122157. PubMed ID: 36055443
[TBL] [Abstract][Full Text] [Related]
6. Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties.
Thakkar R; Zhang Y; Zhang J; Maniruzzaman M
Eur J Pharm Biopharm; 2021 Jun; 163():141-156. PubMed ID: 33838262
[TBL] [Abstract][Full Text] [Related]
7. Novel On-Demand 3-Dimensional (3-D) Printed Tablets Using Fill Density as an Effective Release-Controlling Tool.
Thakkar R; Pillai AR; Zhang J; Zhang Y; Kulkarni V; Maniruzzaman M
Polymers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825229
[TBL] [Abstract][Full Text] [Related]
8. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
9. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
10. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process.
Goyanes A; Allahham N; Trenfield SJ; Stoyanov E; Gaisford S; Basit AW
Int J Pharm; 2019 Aug; 567():118471. PubMed ID: 31252147
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of high melting point hydrochlorothiazide processing via cocrystal formation by hot melt extrusion paired fused filament fabrication as a 3D-printed cocrystal tablet.
Nyavanandi D; Mandati P; Narala S; Alzahrani A; Kolimi P; Pradhan A; Bandari S; Repka MA
Int J Pharm; 2022 Nov; 628():122283. PubMed ID: 36244563
[TBL] [Abstract][Full Text] [Related]
12. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
[TBL] [Abstract][Full Text] [Related]
13. Development of a simple paste for 3D printing of drug formulations containing a mesoporous material loaded with a poorly water-soluble drug.
Katsiotis CS; Tikhomirov E; Leliopoulos C; Strømme M; Welch K
Eur J Pharm Biopharm; 2024 May; 198():114270. PubMed ID: 38537908
[TBL] [Abstract][Full Text] [Related]
14. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
15. Influence of Drug Load on the Printability and Solid-State Properties of 3D-Printed Naproxen-Based Amorphous Solid Dispersion.
Kissi EO; Nilsson R; Nogueira LP; Larsson A; Tho I
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361646
[TBL] [Abstract][Full Text] [Related]
16. Hot Melt Extrusion and its Application in 3D Printing of Pharmaceuticals.
Deshkar S; Rathi M; Zambad S; Gandhi K
Curr Drug Deliv; 2021; 18(4):387-407. PubMed ID: 33176646
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the degradation and in-situ amorphization of the enantiomeric drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing.
Hoffmann L; Breitkreutz J; Quodbach J
Eur J Pharm Sci; 2023 Jun; 185():106423. PubMed ID: 36918059
[TBL] [Abstract][Full Text] [Related]
18. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
20. Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder.
Infanger S; Haemmerli A; Iliev S; Baier A; Stoyanov E; Quodbach J
Int J Pharm; 2019 Jan; 555():198-206. PubMed ID: 30458260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
